VANCOUVER, British Columbia--(BUSINESS WIRE)--Apr 8, 2025--
Leading GNSS data services provider, Rx Networks, unveils TruePoint | FOCUS, a high-precision cloud-based GNSS correction service delivering instantaneous centimeter-level accuracy across a wide range of applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250408494006/en/
TruePoint | FOCUS is designed to meet the demands of applications that require real-time precision without compromise. It supports both RTK (OSR) and PPP-RTK (SSR) modes to deliver flexibility and performance across a range of devices and use cases. The service empowers GNSS receivers with centimeter-level positioning accuracy, enabling a wide array of high-precision use cases in industries such as micro-mobility, smart agriculture, robotics, drones, IoT, and machine control.
The RTK mode is fully hardware-agnostic and compatible with all RTK-capable GNSS receivers, removing the limitations imposed by proprietary ecosystems. TruePoint | FOCUS ensures effortless integration through standard correction protocols like RTCM v3, and supports access via NTRIP, allowing for rapid deployment and minimal integration effort.
In PPP-RTK mode, users can benefit from advanced SSR-based delivery, achieving high-accuracy positioning with optimized bandwidth. TruePoint | FOCUS also supports more GNSS signals than most competing solutions, delivering enhanced resilience and performance in challenging environments.
“Precision means nothing without reliability,” said John Carley, CEO at Rx Networks. “ TruePoint | FOCUS is built on the same ultra-reliable server architecture that powers our Location.io service, which supports critical applications worldwide, ensuring our customers get the accuracy they need, every time.”
TruePoint | FOCUS delivers consistent centimeter-level accuracy with a 99.9% SLA. Its seamless coverage and real-time performance make it ideal for companies operating across North America, Europe, China, and beyond. The correction stream is configurable and includes all available signals across GPS, Galileo, and BeiDou constellations, making TruePoint | FOCUS one of the most comprehensive GNSS correction services on the market.
“With this launch, Rx Networks expands the TruePoint portfolio to include LITE, REACH, and now FOCUS,” said Ali Soliman, VP of Sales and Marketing at Rx Networks. “Together, these offerings address a wide range of use cases balancing accuracy, coverage, cost and hardware compatibility to support the next generation of GNSS applications.”
TruePoint | FOCUS is available today for trial in both RTK and PPP-RTK modes across the covered regions, with more new areas on the roadmap. Users can sign up for a complimentary 30-day trial license at http://www.rxnetworks.com/request-a-free-trial. For further inquiries, contact sales@rxnetworks.com.
About Rx Networks Inc.
Rx Networks is a Canadian company that provides reliable, timely, and relevant location assistance and correction data that improves the GNSS experience and strengthen the connection between people. Billions of devices benefit from Rx Networks GNSS data services every day.
Rx Networks launches TruePoint | FOCUS: Instantaneous Centimeter-Level Accuracy, Effortless setup, Unmatched reliability, Designed for any scale.
LONDON (AP) — King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease.
Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer.
In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can feel “overwhelming,” but said catching the disease early brings “the precious gift of hope.”
Here’s what to know about the king's condition and his message.
The 77-year-old king said in a statement broadcast Friday that his treatment schedule will be reduced in the new year, “thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders.’”
He encouraged others to take advantage of screening programs such as those for breast, bowel and cervical cancer offered by Britain’s public health service.
“Early diagnosis quite simply saves lives,” the king said in the statement aired during a “Stand Up to Cancer” telethon on TV station Channel 4. He said catching the disease early had allowed him “to continue leading a full and active life even while undergoing treatment.”
Charles has received outpatient treatment for almost two years. Buckingham Palace did not say the king is in remission, but that his treatment is moving to a “precautionary phase” and his condition will be monitored to ensure his continued recovery.
“I know from my own experience that a cancer diagnosis can feel overwhelming,” the king said in his video statement. “Yet I also know that early detection is the key that can transform treatment journeys, giving invaluable time to medical teams – and, to their patients, the precious gift of hope.”
Charles announced in February 2024 that he had been diagnosed with cancer, and, in a break from centuries of secrecy about royal health, he has since spoken about the illness, using his story to promote cancer awareness and treatment.
The openness has limits, though. The king has not disclosed what type of cancer he has or what kind of treatment he is receiving. The palace said it was an intentional decision designed to ensure his message reaches the widest possible audience.
The king’s cancer was discovered after treatment for an enlarged prostate. While doctors ruled out prostate cancer, tests revealed “a separate issue of concern,” palace officials said last year.
Charles suspended his public appearances for about two months after his diagnosis. Since returning to the public eye, he has visited cancer treatment centers across the country and shared stories with fellow patients.
Buckingham Palace said Charles “will be greatly encouraged and deeply touched by the very positive reaction" his message has generated. “He will be particularly pleased at the way it has helped to shine a light on the benefits of cancer screening programs,” it added.
British cancer charities said the number of people seeking information about cancer jumped after the king revealed he was undergoing treatment last year.
Cancer Research U.K. said about 100,000 people have visited its Screening Checker website since it was launched on Dec. 5, most of them since the king’s statement on Friday.
The charity's Chief Executive Michelle Mitchell said: “When public figures speak openly about their cancer diagnosis, it can prompt others to check in on their health.”
Broadcaster Jonathan Dimbleby, the king’s authorized biographer, said the statement was “a remarkable thing for a monarch to do.”
“It takes guts, and the fact that he came out and did that will save lives,’” Dimbleby said.
The Princess of Wales, who announced her own cancer diagnosis six weeks after her father-in-law, has also given updates on her treatment. Kate announced in January that her cancer is in remission.
Find more of AP’s coverage at https://apnews.com/hub/royalty
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
